- Trials with a EudraCT protocol (631)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
631 result(s) found for: multiple sclerosis.
Displaying page 25 of 32.
EudraCT Number: 2014-001290-14 | Sponsor Protocol Number: EMR200136_583 | Start Date*: 2014-10-24 |
Sponsor Name:MERCK ROMANIA SRL | ||
Full Title: Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™ | ||
Medical condition: Clinical isolated syndrome and relapse multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004130-14 | Sponsor Protocol Number: IMA 04001 | Start Date*: 2005-02-17 |
Sponsor Name:Biogen Idec GmbH | ||
Full Title: A multicenter, randomized, rater-blind study to compare the efficacy and safety of natalizumab (300 mg IV every four weeks) with Interferon beta-1a (44 mcg SC three times a week) in subjects with r... | ||
Medical condition: Male and female subjects with relapsing multiple sclerosis previously treated with interferon beta-1a (22 mcg or 44 mcg, SC three times a week). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003127-38 | Sponsor Protocol Number: NL71001.029.19 | Start Date*: 2020-04-09 |
Sponsor Name:VUmc Neurology Department | ||
Full Title: Efficacy of add-on high dose simvastatin on markers for disease progression in MS patients treated with ocrelizumab and natalizumab (SIMSON), a phase II clinical trial. | ||
Medical condition: Multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003570-89 | Sponsor Protocol Number: 37559 | Start Date*: 2011-12-02 | |||||||||||
Sponsor Name:VU University Medical Center | |||||||||||||
Full Title: The effect of interferon beta-1a treatment on functional adaptation in Multiple Sclerosis (MS) | |||||||||||||
Medical condition: Multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-004101-40 | Sponsor Protocol Number: OS440-3005 | Start Date*: 2018-03-23 | |||||||||||
Sponsor Name:Osmotica Pharmaceutical US LLC | |||||||||||||
Full Title: An Open-Label Study to Evaluate the Long-Term Safety of Arbaclofen Extended-Release Tablets in Multiple Sclerosis Patients with Spasticity (Study OS440-3005). | |||||||||||||
Medical condition: Spasticity in patients with multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) PL (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001567-55 | Sponsor Protocol Number: DAC-1012 | Start Date*: 2006-06-23 |
Sponsor Name:Protein Design Labs, Inc. | ||
Full Title: A Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study of Subcutaneous Daclizumab in Patients with Active, Relapsing Forms of Multiple Sclerosis | ||
Medical condition: This study is performed in patients with relapsing forms of Multiple Sclerosis. Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), thought ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) GB (Completed) ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002315-98 | Sponsor Protocol Number: MedicalcannabisMSSCI2018 | Start Date*: 2018-12-06 | ||||||||||||||||
Sponsor Name:Aarhus Universitetshospital | ||||||||||||||||||
Full Title: The effect of medical cannabis on neuropathic pain and spasticity in patients with Multiple Sclerosis and in patients with spinal cord injury. A multicenter national placebo-controlled trial | ||||||||||||||||||
Medical condition: Central neuropathic pain and spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004947-21 | Sponsor Protocol Number: CLAD19 | Start Date*: 2019-06-26 | |||||||||||
Sponsor Name:Azienda Ospedaliera Universitaria Integrata Verona | |||||||||||||
Full Title: Exploring the intrathecal anti-inflammatory effect of cladribine and its relationship with clinical efficacy | |||||||||||||
Medical condition: highly active relapsing multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004791-34 | Sponsor Protocol Number: BLOOMS | Start Date*: 2022-03-16 |
Sponsor Name:VU medical center | ||
Full Title: Efficacy, safety and cost-effectiveness of B cell tailored ocrelizumab versus standard ocrelizumab in relapsing remitting multiple sclerosis: a randomized controlled trial | ||
Medical condition: Multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006107-15 | Sponsor Protocol Number: 21-PP-23 | Start Date*: 2022-01-17 | |||||||||||
Sponsor Name:University Nice Hospital | |||||||||||||
Full Title: LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB IN FRENCH PATIENTS WITH PROGRESSIVE MS: CONSONANCE EXTENSION STUDY | |||||||||||||
Medical condition: progressive multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000142-42 | Sponsor Protocol Number: GR-2021-12373041 | Start Date*: 2023-04-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: Exploring the effect of a novel therapy on chronic intrathecal inflammation in patients with active progressive multiple sclerosis | |||||||||||||
Medical condition: patients with secondary progressive MS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003930-16 | Sponsor Protocol Number: SIMCOMBIN | Start Date*: 2006-01-19 | |||||||||||
Sponsor Name:Biogen Idec A/S | |||||||||||||
Full Title: A Multi-centre, Double Blind, Randomised, Placebo Controlled, Parallel Group Study Investigating Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Mu... | |||||||||||||
Medical condition: Patients with definite relapsing-remitting multiple sclerosis who have never received treatment with interferons or glatiramer acetate, who meet all the criteria for inclusion and none of the exclu... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003587-39 | Sponsor Protocol Number: COMBAT-MS | Start Date*: 2017-05-22 |
Sponsor Name:Karolinska Institutet | ||
Full Title: COMBAT-MS (COMparison Between All immunoTherapies for Multiple Sclerosis) A prospective long-term cohort study of safety, efficacy and patient’s satisfaction of MS disease modulatory treatments in... | ||
Medical condition: Relapsing-remitting multiple sclerosis (RRMS) that has started on their first or second immunomodulatory drug at the earliest 2011-01-01 and at the latest 2018-06-30. The clinical course and respon... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003384-30 | Sponsor Protocol Number: IR902-231 | Start Date*: 2007-02-26 |
Sponsor Name:The Immune Response Corporation | ||
Full Title: A Phase II Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for Multiple Sclerosis | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000171-18 | Sponsor Protocol Number: 3066A2-214-WW | Start Date*: 2005-05-12 |
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. Clinical Research and Development | ||
Full Title: A Multi-center, Open-label Extension Study of the Safety and Tolerability of Long-term Administration of Oral CCI-779 (Temsirolimus) in Subjects with Relapsing Multiple Sclerosis Who Completed Stud... | ||
Medical condition: Multiple Sclerosis (Relapsing-remitting MS and Secondary progressive MS with relapses) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002138-13 | Sponsor Protocol Number: GWSP0702 | Start Date*: 2007-09-13 |
Sponsor Name:GW Pharma Ltd. | ||
Full Title: A placebo controlled, parallel group, randomised withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term GW-1000-02 (Sativex®). | ||
Medical condition: Symptoms of spasticity in multiple sclerosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001197-18 | Sponsor Protocol Number: NOR-BGT-14-10665 | Start Date*: 2015-05-20 |
Sponsor Name:Biogen Idec Norway | ||
Full Title: The effect of Tecfidera® (Dimethyl Fumarate) on the gut microbiota as a causal factor for GI associated adverse events. | ||
Medical condition: multiple sclerosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000434-21 | Sponsor Protocol Number: PRT-PEG-15-10880 | Start Date*: 2016-11-14 | |||||||||||
Sponsor Name:Biogen Portugal | |||||||||||||
Full Title: PLENO – Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients with Relapsing Remitting Multiple Sclerosis (MS) Transitioning from Current... | |||||||||||||
Medical condition: Relapsing-remitting multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000029-28 | Sponsor Protocol Number: P3-IMU-838-RMS-02 | Start Date*: 2022-09-05 | |||||||||||
Sponsor Name:Immunic AG | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2) | |||||||||||||
Medical condition: Relapsing Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005493-11 | Sponsor Protocol Number: CHPAU2014/01 | Start Date*: 2015-08-31 |
Sponsor Name:Centre Hospitalier de Pau | ||
Full Title: Intrathecal Rituximab in Progressive Multiple Sclerosis | ||
Medical condition: Patients included in our study suffer from a progressive form of Multiple sclerosis and will be treated by intravenous and intrathecal rituximab, with intravenous methylprednisolone. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
